Alvin Luk, Senior Vice President and Chief Medical Officer at Shanghai Henlius
Biotech Inc., holds an MBA from Harvard Business School, earned his doctoral
degree in Neuroscience from the University of California San Francisco Medical
School (UCSF) and is certified for clinical research from the Association of
Clinical Research Professionals. Previously,Dr. Luk has held executive
positions at companies such as Spark, Biogen, BayerAG, Avigen (Sanofi) and
Tularik (Amgen). He has over 26 years of global drug development, strategic
management and clinical medical leadership experience. During 2006-2009, Dr.
Luk was a member of the USA FDA Clinical Design Committee focusing on adaptive
clinical trial designs to shorten drug development timeline.
diseases, Biologics and Regenerative medicines